Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
This transcript has been edited for clarity.
Hi. Today I'm going to give you a few updates on COVID-19 and diabetes.
The Good
First, we've learned that telemedicine works for helping people with diabetes. We always thought it would work, but now we know it works. We have studies from Spain, Italy, the United States, and many other countries that show we can provide equivalent or even better care through telemedicine than in person.
Now, this means we're good at managing glucose levels as long as we have data. We have to be able to do true remote management, which means we need to be able to get the data from our patients in order to help manage their blood sugars. I think it's very important to prove that we can do that and do that effectively.
We've also shown that we can use continuous glucose monitors (CGM) in the hospital. Ever since the emergency ruling passed from the FDA allowing CGMto be used in the inpatient setting, a number of hospitals have implemented CGM, and they have shown that it's quite helpful. I'm hopeful that we'll be able to continue using CGM in hospitalized patients.
COMMENTARY
A COVID-19 and Diabetes Update From Anne Peters
Anne L. Peters, MD
DisclosuresDecember 04, 2020
Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
This transcript has been edited for clarity.
Hi. Today I'm going to give you a few updates on COVID-19 and diabetes.
The Good
First, we've learned that telemedicine works for helping people with diabetes. We always thought it would work, but now we know it works. We have studies from Spain, Italy, the United States, and many other countries that show we can provide equivalent or even better care through telemedicine than in person.
Now, this means we're good at managing glucose levels as long as we have data. We have to be able to do true remote management, which means we need to be able to get the data from our patients in order to help manage their blood sugars. I think it's very important to prove that we can do that and do that effectively.
We've also shown that we can use continuous glucose monitors (CGM) in the hospital. Ever since the emergency ruling passed from the FDA allowing CGMto be used in the inpatient setting, a number of hospitals have implemented CGM, and they have shown that it's quite helpful. I'm hopeful that we'll be able to continue using CGM in hospitalized patients.
Medscape Diabetes © 2020 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Anne L. Peters. A COVID-19 and Diabetes Update From Anne Peters - Medscape - Dec 04, 2020.
Tables
Authors and Disclosures
Authors and Disclosures
Author(s)
Anne L. Peters, MD
Professor, Department of Clinical Medicine, Keck School of Medicine; Director, University of Southern California Westside Center for Diabetes, University of Southern California, Los Angeles, California
Disclosure: Anne L. Peters, MD, has disclosed the following relevant financial relationships:
Serve(d) on the advisory board for: Abbott Diabetes Care; Becton Dickinson; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; Lexicon Pharmaceuticals, Inc.; Livongo; Medscape; Merck & Co., Inc.; Novo Nordisk; Omada Health; OptumHealth; sanofi; Zafgen
Received research support from: Dexcom; MannKind Corporation; Astra Zeneca
Serve(d) as a member of a speakers bureau for: Novo Nordisk